Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Literature DB >> 19075048

In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Kristina Morgenstern¹, Georg Baljer, Douglas E Norris, Peter Kraiczy, Christa Hanssen-Hübner, Klaus-Peter Hunfeld.

Abstract

Ten isolates of the recently delineated genospecies Borrelia spielmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern of B. spielmanii mainly parallels that of the other known human-pathogenic members of the B. burgdorferi sensu lato complex.

Entities: Disease Species

Mesh：

Substances：
Anti-Infective Agents

Year: 2008 PMID： 19075048 PMCID： PMC2650570 DOI： 10.1128/AAC.01247-08

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

29 in total

1. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.

Authors: A G Barbour
Journal: J Clin Microbiol Date: 1988-03 Impact factor: 5.948

2. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.

Authors: Klaus-Peter Hunfeld; Eva Ruzic-Sabljic; Douglas E Norris; Peter Kraiczy; Franc Strle
Journal: Antimicrob Agents Chemother Date: 2005-04 Impact factor: 5.191

3. [Genetic characterization of pathogenic Borrelia, group A14S, isolated in Ukraine].

Authors: V V Nefedova; E I Korenberg; Iu V Andreĭchuk; N B Gorelova; A V Markov; I A Fadeeva; I L Evstaf'ev
Journal: Zh Mikrobiol Epidemiol Immunobiol Date: 2005 Jul-Aug

4. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis.

Authors: G Wang; A P van Dam; J Dankert
Journal: J Clin Microbiol Date: 1999-09 Impact factor: 5.948

5. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.

Authors: P Brouqui; F Bacellar; G Baranton; R J Birtles; A Bjoërsdorff; J R Blanco; G Caruso; M Cinco; P E Fournier; E Francavilla; M Jensenius; J Kazar; H Laferl; A Lakos; S Lotric Furlan; M Maurin; J A Oteo; P Parola; C Perez-Eid; O Peter; D Postic; D Raoult; A Tellez; Y Tselentis; B Wilske
Journal: Clin Microbiol Infect Date: 2004-12 Impact factor: 8.067

6. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe.

Authors: Dania Richter; Daniela B Schlee; Rainer Allgöwer; Franz-Rainer Matuschka
Journal: Appl Environ Microbiol Date: 2004-11 Impact factor: 4.792

7. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.

Authors: V Preac Mursic; W Marget; U Busch; D Pleterski Rigler; S Hagl
Journal: Infection Date: 1996 Jan-Feb Impact factor: 3.553

8. Analysis and comparison of plasmid profiles of Borrelia burgdorferi sensu lato strains.

Authors: Y Xu; R C Johnson
Journal: J Clin Microbiol Date: 1995-10 Impact factor: 5.948

9. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.

Authors: D Postic; M V Assous; P A Grimont; G Baranton
Journal: Int J Syst Bacteriol Date: 1994-10